These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10999817)

  • 1. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3251-5. PubMed ID: 10999817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
    Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
    Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
    J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
    Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
    Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
    Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
    Ibáñez L; Diaz M; Sebastiani G; Sánchez-Infantes D; Salvador C; Lopez-Bermejo A; de Zegher F
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3361-6. PubMed ID: 21865363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
    Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
    Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
    Moghetti P; Tosi F; Castello R; Magnani CM; Negri C; Brun E; Furlani L; Caputo M; Muggeo M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):952-60. PubMed ID: 8772557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low dose of flutamide in the treatment of hyperandrogenism.
    Fulghesu AM; Melis F; Murru G; Canu E; Melis GB
    Gynecol Endocrinol; 2018 May; 34(5):394-398. PubMed ID: 29108453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
    Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.